Optimization of large-scale production process for human prothrombin complex concentrates
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 12
Abstract
Objective To determine the optimal process conditions for efficiently extracting human prothrombin complex concentrates from human plasma. Methods Using human plasma as the materials and the yield of prothrombin complex concentrates as the evaluation standard, the preparation process parameters were studied and optimized through design of exporement(DOE), orthogonal experiments, and single factor experiments. Results The optimal process conditions were as follows: DEAE Sephadex A50 gel was selected, which balanced to pH 7.6, and then the amount of 1.7-2.5 g/L of plasma weight is added into the cryoprecipitate supernatant for adsorption for 40 minutes; Washing solution (0.15-0.175 mol/L sodium chloride) with 3 times the volume of gel was washed 3 times, and eluent (0.5-2.0 mol/L sodium chloride) was washed 3 to 5 times; Add stabilizer (heparin 35 IU, sodium chloride 0.1 mol/L) for ultrafiltration dialysis. Conclusion By using the optimized process mentioned above, the yield(measured by human coagulation factor IX)can reach 620 000 to 630 000 IU/ton of plasma, which is suitable for large-scale production.
Authors and Affiliations
Liangchao ZHAO, Guanjun LI, Xiaowei MA, Dongsheng ZHAO, Minghua WNAG, Bo SONG
Keywords
Related Articles
- EP ID EP738724
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.12.015
- Views 64
- Downloads 0
Analyse the risk factors for producing anti-HLA antibodies in patients with hematological diseases
Objective To explore the risk factors for the production of anti-HLA antibodies in patients with hematological diseases before hematopoietic stemcell transplantation. Methods The results and clinical data of 1 008 patien...
Influence of blood donation service on the autonomous motivation of blood donors
Objective To explore the influence of blood donors′ demographic characteristics and blood donation service experience on voluntary blood donation motivation. Methods Using self-made questionnaire, stratified sampling met...
Evaluation and analysis of bleeding risk of anticoagulation therapy in severe non-ICU patients with COVID-19 based on heparinase-modified TEG
Objective To investigate the clinical application of heparinase-modified TEG (hmTEG) in evaluating coagulation status and monitoring anticoagulant therapy in severe non-ICU patients with COVID-19. Methods The clinical da...
Serological and molecular characterization of HBV infection with HBsAg reactive and HBV DNA non-reactive
Objective To investigate the serological and molecular characteristics of HBsAg+ /HBV DNA non-reactive (NR) infections. Methods Samples tested as HBsAg+ and HBV DNA NR were confirmed by individual NAT repeat testing, vir...
Analysis of blood donor pre-donation deferral in Zhengzhou
Objective To identify low-risk donor population and optimize blood screening, recruitment and consultation strategies via retrospectively analyzing the unqualified results of Hb, ALT, HBsAg, TP before whole blood donatio...